Kinase fusions have been identified in distinct histological subtypes of thyroid cancer, including papillary thyroid cancer (PTC; RET, NTRK1/2/3), medullary thyroid cancer (ALK), and poorly differentiated thyroid cancer (RET, ALK) (5,9,10). This evidence concerns the gene ALK and medullary thyroid gland carcinoma.